Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 257 record(s)

Req # A-2021-000148

Adverse Drug Reaction (ADR). Report number: E2B_03423266.

Organization: Health Canada

31 page(s)
November 2021

Req # A-2021-000355

Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_02379623.

Organization: Health Canada

13 page(s)
November 2021

Req # A-2021-000427

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102050-179, Virtual Healthcare Conference: How to Fix Canada’s PPE Supply Chain? Building a National Marketplace After COVID-19.

Organization: Health Canada

5 page(s)
November 2021

Req # A-2021-000507

Adverse Drug Reaction (ADR) for ALEMTUZUMAB. Report number: E2B_03394016.

Organization: Health Canada

20 page(s)
November 2021

Req # A-2021-000569

Adverse Drug Reaction (ADR) for INSULIN GLARGINE. Report number: E2B_03313409.

Organization: Health Canada

7 page(s)
November 2021

Req # A-2021-000886

Adverse Drug Reaction (ADR) for Hizentra. Report number: E2B_03743938.

Organization: Health Canada

18 page(s)
November 2021

Req # A-2021-000998

Adverse Drug Reactions (ADRs) for FLUDARABINE PHOSPHATE. Report numbers: E2B_03817011, E2B_03542554.

Organization: Health Canada

28 page(s)
November 2021

Req # A-2021-001003

Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: E2B_04017773, E2B_04415252, E2B_03992837.

Organization: Health Canada

155 page(s)
November 2021

Req # A-2021-001020

Adverse Drug Reaction (ADR) for IRBESARTAN. Report number: E2B_03595491.

Organization: Health Canada

16 page(s)
November 2021

Req # A-2021-001114

Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_02615649.

Organization: Health Canada

14 page(s)
November 2021
Date modified: